Zoledronic acid api?

Do you mean the Active Pharmaceutical Ingredient (API) when you say “api”?

If so, here’s a quick overview of zoledronic acid as an API:

- What it is: A nitrogen-containing bisphosphonate used as the active ingredient in IV medicines to treat osteoporosis and cancer-related bone disease.
- Mechanism: Inhibits osteoclast-mediated bone resorption by blocking farnesyl pyrophosphate synthase in the mevalonate pathway, leading to reduced bone breakdown.
- Common indications (clinical use): Osteoporosis in postmenopausal women and men; hypercalcemia of malignancy; bone metastases and multiple myeloma-related bone disease.
- Formulation for administration: Typically supplied as API for intravenous infusion products (e.g., as a solid to be reconstituted and infused).
- Key safety considerations (for API handling and clinical use): Requires medical supervision. Risks include hypocalcemia, renal impairment, acute-phase reactions after infusion, osteonecrosis of the jaw, and other serious adverse effects. Calcium, phosphate, and renal function should be monitored; pregnancy is contraindicated.
- About identifiers (if you need them):
- INN: zoledronic acid
- Brand names of products containing it include Zometa, Aclasta (these are formulations, not the API itself)
- If you want exact identifiers like CAS number, PubChem CID, or IUPAC name for the Zoledronic acid API, tell me and I can fetch them.

If you’re looking for something more specific (e.g., API purity specs, typical impurity limits, packaging formats, supplier RFQ language, or regulatory data sheets), tell me which details you need and I’ll tailor it.